Unlock stock picks and a broker-level newsfeed that powers Wall Street.
NYSE American - Nasdaq Real Time Price USD

Neuberger Berman High Yield Strategies Fund Inc. (NHS)

Compare
7.61
-0.05
(-0.72%)
At close: April 3 at 4:00:00 PM EDT
Loading Chart for NHS
  • Previous Close 7.66
  • Open 7.60
  • Bid 7.52 x 900
  • Ask --
  • Day's Range 7.58 - 7.64
  • 52 Week Range 7.47 - 8.67
  • Volume 182,978
  • Avg. Volume 195,775
  • Market Cap (intraday) 228.903M
  • Beta (5Y Monthly) 0.84
  • PE Ratio (TTM) 5.28
  • EPS (TTM) 1.44
  • Earnings Date --
  • Forward Dividend & Yield 1.09 (14.27%)
  • Ex-Dividend Date Apr 15, 2025
  • 1y Target Est --

Neuberger Berman High Yield Strategies Fund Inc. is a closed-ended fixed income mutual fund launched by Neuberger Berman LLC. The fund is managed by Neuberger Berman Investment Advisers LLC. It invests in fixed income markets across the globe. The fund typically invests in high yield debt securities of various sectors, such as auto parts and equipment, airlines, automotive, electronics, health services, packaging, telecom-integrated/services, gaming, and gas distribution. It was formerly known as Neuberger Berman High Yield Strategies Fund. Neuberger Berman High Yield Strategies Fund Inc. was formed on July 28, 2003 and is domiciled in the United States.

www.nb.com/Pages/Public/en-us/Products/high-yield-strategies-fund.aspx

--

Full Time Employees

October 31

Fiscal Year Ends

Recent News: NHS

View More

Performance Overview: NHS

Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

NHS
5.28%
S&P 500 (^GSPC)
8.25%

1-Year Return

NHS
8.46%
S&P 500 (^GSPC)
3.55%

3-Year Return

NHS
1.63%
S&P 500 (^GSPC)
18.71%

5-Year Return

NHS
64.76%
S&P 500 (^GSPC)
116.85%

Compare To: NHS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: NHS

View More

Valuation Measures

Annual
As of 4/3/2025
  • Market Cap

    228.90M

  • Enterprise Value

    --

  • Trailing P/E

    5.28

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    5.42

  • Price/Book (mrq)

    0.98

  • Enterprise Value/Revenue

    6.53

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    166.39%

  • Return on Assets (ttm)

    3.99%

  • Return on Equity (ttm)

    17.70%

  • Revenue (ttm)

    22.8M

  • Net Income Avi to Common (ttm)

    37.94M

  • Diluted EPS (ttm)

    1.44

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    35.64%

  • Levered Free Cash Flow (ttm)

    13.75M

Research Analysis: NHS

View More

Company Insights: NHS

Research Reports: NHS

View More

People Also Watch